Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Colleen’s Dream Foundation, with the Million Dollar Round Table Foundation (MDRTF), Gifts $10,000 to the University of Chicago for Ovarian Cancer Research
  • USA - English


News provided by

Colleen's Dream Foundation

Feb 11, 2016, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Colleen Drury - The Inspiration for Colleen's Dream Foundation
Colleen Drury - The Inspiration for Colleen's Dream Foundation

Phoenix, AZ (PRWEB) February 11, 2016 -- As part of their 2015 end of year funding strategy, Colleen’s Dream Foundation, with support of the Million Dollar Round Table Foundation (MDRTF), has gifted $10,000 to University of Chicago to support ovarian cancer research being conducted by Dr. Karen Watters, according to Colleen’s Dream Foundation President Billy Cundiff.

Dr. Karen Watters is performing valuable microRNA research which can help in the battle to defeat ovarian cancer.” Colleen's Dream Foundation President Billy Cundiff

Post this

“We are honored to support a promising young investigator from Dr. Lengyel’s lab at the University of Chicago,” says Cundiff. “Dr. Karen Watters is performing valuable microRNA research which can help in the battle to defeat ovarian cancer.”

According to Dr. Watters, the microRNA research she is focused on has important implications for the long-term survival of ovarian cancer patients.

“Although the majority of high-grade serous ovarian cancer patients initially respond well to chemotherapy, most will eventually relapse and succumb to chemoresistant disease,” says Dr. Watters. “My research focuses on the microRNAs (regulatory short non-coding RNAs) of not just the tumor itself, but also the tumor microenvironment and how the cross-communication between these two compartments can contribute to both innate and acquired resistance to chemotherapy in these patients.”

Dr. Watters says understanding why ovarian cancers stop responding to chemotherapy may be key to understanding the disease itself. She says support from organizations like Colleen’s Dream Foundation and the Million Dollar Round Table, is important in allowing her to pursue this question.

“This gift will allow me to study unique aspects of the mechanism of ovarian cancer seeding and why these cancers stop responding to chemotherapy,” says Watters. “This additional knowledge has the potential to help us gain further insight into the biology of this disease.”

Cundiff says supporting ovarian cancer research like Dr. Watters is the goal of Colleen’s Dream.

“Colleen’s Dream is honored to support Dr. Watters’ work,” says Cundiff. “We are truly excited about the possible impact her research may have in defeating ovarian cancer.”

ABOUT THE UNIVERSITY OF CHICAGO MEDICINE AND BIOLOGICAL SCIENCES

The University of Chicago Medicine and Biological Sciences one of the nation's leading academic medical institutions, has been at the forefront of medical care since 1927, when it first opened to patients. Today, it comprises the University of Chicago Pritzker School of Medicine, a top 10 medical school in the country; the University of Chicago Biological Sciences Division, a section committed to scientific discovery; and the University of Chicago Medical Center, consistently ranked among the best hospitals in the nation by U.S. News & World Report. Twelve Nobel Prize winners in physiology or medicine have been affiliated with the University of Chicago Medicine.

ABOUT THE MILLION DOLLAR ROUND TABLE FOUNDATION (MDRTF)

The MDRT Foundation is the charitable arm of the Million Dollar Round Table, The Premier Association of Financial Professionals. The MDRT Foundation helps MDRT members maximize their philanthropic efforts in their own communities and worldwide.

In 1956, MDRT President, Arthur F. Priebe, CLU directed a corporate charitable gift in his honor to support the larger needs of the community, which led to the creation of the MDRT Foundation in 1959. During the next 10 years, MDRT members pooled their resources together to strengthen this newly founded charitable organization. By combining the generosity of each contributor, the MDRT Foundation is a powerful vehicle to maximize the global impact of MDRT members committed to improving the life of children and families in need in communities worldwide.

Since 1959, the MDRT Foundation has awarded more than USD 30 million in life-changing grants to charitable organizations worldwide. MDRT Foundation grants support social service agencies, education and advocacy programs, medical agencies and many other causes committed to empowering people in need. Some of the organizations that have received funding include Make-A-Wish International, Habitat for Humanity, Heifer International and The Salvation Army.

ABOUT COLLEEN’S DREAM FOUNDATION:

Colleen’s Dream Foundation started in 2012 and supports research for early detection and improved treatment for ovarian cancer. The story of Colleen’s Dream started in 2007 when Colleen Drury –Nicole Cundiff’s mother and Billy Cundiff’s mother-in-law- was diagnosed with late-stage ovarian cancer. The family became aware of a new world that was filled with invasive surgery, harsh chemotherapy, and lots of uncertainty, and realized they needed to help others who were dealing with ovarian cancer.

Colleen’s Dream Foundation believes it is important to raise money for research that will lead to reliable early detection testing and improved treatment for ovarian cancer. Because so little is known about ovarian cancer in proportion to other women’s health issues, there is an incredible opportunity for research and education.

Colleen's Dream Foundation is a qualified 501 (c) (3) tax exempt non-profit organization based in Phoenix, Arizona.

Billy Cundiff, Colleen's Dream Foundation, +1 (480) 269-2266, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.